Scarica l'app Stockscreener
25.32
4.70%
-1.25
Dopo l'orario di chiusura:
25.59
0.27
+1.07%
Precedente Chiudi:
$26.57
Aprire:
$26.46
Volume 24 ore:
1.84M
Relative Volume:
0.42
Capitalizzazione di mercato:
$1.58B
Reddito:
$14.34M
Utile/perdita netta:
$-199.00M
Rapporto P/E:
-6.4592
EPS:
-3.92
Flusso di cassa netto:
$-183.51M
1 W Prestazione:
-9.44%
1M Prestazione:
-62.59%
6M Prestazione:
+74.80%
1 anno Prestazione:
+255.12%
Intervallo 1D:
$24.97
$26.46
Intervallo di 1 settimana:
$24.97
$28.50
Portata 52W:
$6.11
$71.50
Uniqure N V Stock (QURE) Company Profile
Nome
Uniqure N V
Settore
Industria
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Confronta QURE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
25.32 | 1.66B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.15 | 107.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
742.00 | 78.84B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.93 | 60.05B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
915.36 | 55.10B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.60 | 45.09B | 447.02M | -1.18B | -906.14M | -6.1812 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-04-01 | Ripresa | Chardan Capital Markets | Buy |
| 2024-12-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-02-29 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-19 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-17 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-11-09 | Iniziato | Jefferies | Buy |
| 2020-11-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-08-25 | Iniziato | Raymond James | Strong Buy |
| 2020-07-31 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Downgrade | Mizuho | Buy → Neutral |
| 2020-06-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Iniziato | Cowen | Outperform |
| 2019-12-03 | Iniziato | Goldman | Buy |
| 2019-11-05 | Iniziato | Credit Suisse | Outperform |
| 2019-10-11 | Iniziato | Stifel | Buy |
| 2019-09-25 | Iniziato | Bernstein | Outperform |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-07-30 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-07-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-03-29 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Uniqure N V Borsa (QURE) Ultime notizie
How uniQure N.V. stock performs in weak economy2025 Stock Rankings & AI Forecasted Stock Moves - Newser
Will uniQure N.V. (UQ1) stock sustain uptrend momentumJuly 2025 Momentum & Community Consensus Picks - Newser
Can uniQure N.V. (UQ1) stock sustain revenue momentumWeekly Profit Report & Detailed Earnings Play Strategies - Newser
How uniQure N.V. (UQ1) stock benefits from digital adoption2025 Key Lessons & Breakout Confirmation Alerts - Newser
Will uniQure N.V. (UQ1) stock draw ESG focused fundsTrade Signal Summary & Entry Point Strategy Guides - Newser
Can uniQure N.V. stock sustain institutional interestWeekly Profit Recap & Free Long-Term Investment Growth Plans - Newser
ETF Watch: How strong is uniQure NV stock revenue growthJuly 2025 Rallies & Stock Portfolio Risk Management - BỘ NỘI VỤ
How uniQure N.V. stock benefits from tech adoptionEarnings Growth Report & Expert Curated Trade Setups - BỘ NỘI VỤ
Is uniQure N.V. stock positioned for long term growthQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - moha.gov.vn
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Your Wyoming Link
How sustainable is uniQure N.V. stock dividend payoutJuly 2025 Opening Moves & Stepwise Trade Signal Guides - moha.gov.vn
Market Pulse: Can uniQure N.V. stock surprise with earnings upsideWeekly Investment Report & Technical Entry and Exit Tips - BỘ NỘI VỤ
uniQure put volume heavy and directionally bearish - TipRanks
uniQure N.V. (QURE) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
uniQure (QURE) Is Down 5.9% After FDA Calls AMT-130 Data Insufficient for BLA Approval – Has the Bull Case Changed? - simplywall.st
uniQure is Now Oversold (QURE) - Nasdaq
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty - MSN
Certain Performance Stock of uniQure N.V. are subject to a Lock-Up Agreement Ending on 25-NOV-2025. - MarketScreener
Certain Options of uniQure N.V. are subject to a Lock-Up Agreement Ending on 25-NOV-2025. - MarketScreener
Certain Ordinary Shares of uniQure N.V. are subject to a Lock-Up Agreement Ending on 25-NOV-2025. - MarketScreener
QURE Investigation Alert: Kessler Topaz Meltzer & Check, - GlobeNewswire
QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - GlobeNewswire Inc.
A significant driver of top-line growth: uniQure N.V (QURE) - Setenews
9 Oversold Biotech Stocks to Invest In - Insider Monkey
uniQure NV Faces Weak Start with 5.08% Gap Down Amid Market Concerns - Markets Mojo
QURE Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Eastern Progress
uniQure (NASDAQ:QURE) Downgraded by Wall Street Zen to “Sell” - Defense World
(QURE) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
Why uniQure N.V. (UQ1) stock is trending on social mediaJuly 2025 Breakouts & AI Optimized Trade Strategies - newser.com
How currency fluctuations impact uniQure N.V. stock - newser.com
Is uniQure N.V. stock a buy on dipsTrade Analysis Report & Daily Volume Surge Signals - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V.QURE - PR Newswire
Will uniQure N.V. stock deliver shareholder valueJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Is uniQure N.V. (UQ1) stock supported by strong fundamentals - newser.com
Reviewing uniQure (NASDAQ:QURE) and Biogen (NASDAQ:BIIB) - Defense World
Published on: 2025-11-19 17:01:52 - newser.com
Can uniQure N.V. stock hit record highs againTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
Predicting uniQure N.V. trend using moving averagesJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - MSN
Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3 - Insider Monkey
Can uniQure N.V. stock hit analyst price targetsTrade Risk Report & Safe Entry Point Identification - newser.com
Uniqure N V Azioni (QURE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
1.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):